Cim, LLC Horizon Therapeutics Public LTD CO Transaction History

Cim, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 11, 2022	BUY	$79.4 - $116.36 $56,215 - $82,382	708 Added 6.16%	12,200 $1.02 Million
Q1 2022 Apr 12, 2022	BUY	$86.42 - $109.81 $10,975 - $13,945	127 Added 1.12%	11,492 $1.29 Million
Q4 2021 Jan 26, 2022	SELL	$98.56 - $119.91 $191,403 - $232,865	-1,942 Reduced 14.59%	11,365 $984,000
Q3 2021 Nov 08, 2021	BUY	$91.91 - $110.37 $25,367 - $30,462	276 Added 2.12%	13,307 $1.47 Million
Q2 2021 Aug 09, 2021	BUY	$86.24 - $95.92 $17,420 - $19,375	202 Added 1.57%	13,031 $1.38 Million
Q1 2021 May 11, 2021	BUY	$71.83 - $95.48 $921,507 - $1.22 Million	12,829 New	12,829 $1.11 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Cim, LLC, based on Form 13F filings with the SEC.

Stay updated on Cim, LLC with notifications on news.